The FDA recommended discontinuing Zantac use in September 2019 and officially recalled the drug in April 2020. Since the recall, multiple plaintiffs have filed legal complaints alleging that Zantac use led them to a cancer diagnosis.
Besides the U.S., over 40 other countries have recalled, banned, or issued warnings about Zantac, including Canada, Germany, France, Italy, Ireland, the United Kingdom, Australia, New Zealand, Japan, and South Korea.
The online pharmacy Valisure first alerted the U.S. Food and Drug Administration (FDA) in September 2019 about unsafe amounts of N-Nitrosodimethylamine (NDMA) contamination in the heartburn medication Zantac (generic name ranitidine). Congresswoman Rosa L. DeLauro stepped in and wrote a letter, urging the FDA to remove Zantac from the shelves and ban the medication due to cancer risk.
Ranitidine poses a significant risk to public health and safety, and it is imperative that swift action is taken…Valisure’s data, in combination with four decades of scientific research, strongly suggests that ranitidine is fundamentally unstable molecule and all products containing this drug have risk of cancer. It is incomprehensible that the FDA is fully aware of this fact, yet, it continues to allow this drug to remain on the shelves.
There are times that manufacturers refuse to remove products from shelves, despite risk to public health. According to her website, Congresswoman Rosa L. Delauro reintroduced the Recall Unsafe Drugs Act, which would give the FDA to mandatory recall authority over drugs and homeopathic products.
With these discoveries and other research by our attorneys, Childers, Schlueter & Smith may be able to help you. If you have been injured after taking Zantac, please give us a call for a free consultation at 404-419-9500. You can find further information about Zantac right here on our website.